Immunotherapy has become an important part of the oncotherapy arsenal. Its applicability in
various cancer types is impressive, as well as its use of endogenous mechanisms to achieve …

With an understanding of immunity in the tumor microenvironment, immunotherapy turns out
to be a powerful tool in the clinic to treat many cancers. The strategies applied in cancer …

Chimeric antigen receptor (CAR) T cells therapy has emerged as a significant breakthrough
in adoptive immunotherapy for hematological malignancies with FDA approval. However …

Primary brain and central nervous system (CNS) tumors are a diverse group of neoplasms
that occur within the brain and spinal cord. Although significant advances in our …

Numerous benefits of nanotechnology are available in many scientific domains. In this
sense, nanoparticles serve as the fundamental foundation of nanotechnology. Recent …

Adoptive cell therapy with chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) has
emerged as an innovative immunotherapy for hematological cancer treatment. However, the …

Cancer immunotherapy has sparked a wave of cancer research, driven by recent successful
proof-of-concept clinical trials. However, barriers are emerging during its rapid development …

Despite advancements in the development of anticancer medications and therapies, cancer
still has the greatest fatality rate due to a dismal prognosis. Traditional cancer therapies …

Adoptive cell therapy (ACT) harnesses the capabilities of immune cells to fight complex
diseases such as cancer. Treatment with adoptive transfer of engineered cells has led to …

Objectives Iron oxide nanoparticles have been used to track the accumulation of chimeric
antigen receptor (CAR) T cells with magnetic resonance imaging (MRI). However, the only …